CYP4A22
| cytochrome P450, family 4, subfamily A, polypeptide 22 | |
|---|---|
| Identifiers | |
| Symbol | CYP4A22 |
| Entrez | 284541 |
| HUGO | 20575 |
| RefSeq | XM_208213 |
| UniProt | Q5TCH4 |
| Other data | |
| EC number | 1.14.15.3 |
| Locus | Chr. 1 p33 |
|
WikiDoc Resources for CYP4A22 |
|
Articles |
|---|
|
Most recent articles on CYP4A22 |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on CYP4A22 at Clinical Trials.gov Clinical Trials on CYP4A22 at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on CYP4A22
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Directions to Hospitals Treating CYP4A22 Risk calculators and risk factors for CYP4A22
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for CYP4A22 |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
CYP4A22 (cytochrome P450, family 4, subfamily A, polypeptide 22) also known as fatty acid omega-hydroxylase is a protein which in humans is encoded by the CYP4A22 gene.[1]
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This gene is part of a cluster of cytochrome P450 genes on chromosome 1p33.[2]
References
- ↑ Hiratsuka M, Nozawa H, Katsumoto Y, Moteki T, Sasaki T, Konno Y, Mizugaki M (2006). "Genetic polymorphisms and haplotype structures of the CYP4A22 gene in a Japanese population". Mutat. Res. 599 (1–2): 98–104. doi:10.1016/j.mrfmmm.2006.02.008. PMID 16806293. Unknown parameter
|month=ignored (help) - ↑ "Entrez Gene: CYP4A22".
This article incorporates text from the United States National Library of Medicine, which is in the public domain.